CARB-X A Stronger Path Forward for Infection Control and Antimicrobial Resistance: Learning From COVID-19 Read more
Antibiotics Aren’t Profitable Enough for Big Pharma to Make More Kevin Outterson is quoted in “Antibiotics Aren’t Profitable Enough for Big Pharma to Make More,” Bloomberg Businessweek Share this:FacebookTwitterLinkedIn